Literature DB >> 32645725

Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.

Emmanuel Weiss1,2,3, Olivier Roux4, Jean-Denis Moyer1, Catherine Paugam-Burtz1,2, Larbi Boudaoud5, Nadine Ajzenberg6,7, Dorothée Faille6,7, Emmanuelle de Raucourt5,7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32645725     DOI： 10.1055/s-0040-1713637

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  11 in total

Review 1.  COVID-19 and coagulopathy.

Authors:  Malay Sarkar; Irappa V Madabhavi; Pham Nguyen Quy; Manjunath B Govindagoudar
Journal:  Clin Respir J       Date:  2021-08-30       Impact factor: 1.761

2.  Fibrinolysis and D-dimer in COVID-19: A Twisted Plot!

Authors:  Rohan Magoon; Nitin Choudhary; Jes Jose
Journal:  Indian J Crit Care Med       Date:  2022-02

Review 3.  Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation.

Authors:  Connor M Bunch; Ernest E Moore; Hunter B Moore; Matthew D Neal; Anthony V Thomas; Nuha Zackariya; Jonathan Zhao; Sufyan Zackariya; Toby J Brenner; Margaret Berquist; Hallie Buckner; Grant Wiarda; Daniel Fulkerson; Wei Huff; Hau C Kwaan; Genevieve Lankowicz; Gert J Laubscher; Petrus J Lourens; Etheresia Pretorius; Maritha J Kotze; Muhammad S Moolla; Sithembiso Sithole; Tongai G Maponga; Douglas B Kell; Mark D Fox; Laura Gillespie; Rashid Z Khan; Christiaan N Mamczak; Robert March; Rachel Macias; Brian S Bull; Mark M Walsh
Journal:  Front Surg       Date:  2022-05-04

4.  Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?

Authors:  Etienne de Montmollin; Dorothée Faille; Valérie Andrieu; Nadine Ajzenberg; Jean-François Timsit
Journal:  J Infect       Date:  2021-02-05       Impact factor: 6.072

Review 5.  Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.

Authors:  Jonathan P Meizoso; Hunter B Moore; Ernest E Moore
Journal:  J Am Coll Surg       Date:  2021-03-22       Impact factor: 6.113

Review 6.  Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Shelley E Haydel; Alexandra R Lucas
Journal:  Front Cardiovasc Med       Date:  2021-03-25

Review 7.  Coagulopathy during COVID-19 infection: a brief review.

Authors:  Robin M Cunningham; Kyle L Johnson Moore; Jacen S Moore
Journal:  Clin Exp Med       Date:  2022-09-19       Impact factor: 5.057

Review 8.  The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.

Authors:  Nicola Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

9.  Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?

Authors:  Nathan D Nielsen; Marian A Rollins-Raval; Jay S Raval; Jecko Thachil
Journal:  Thromb Res       Date:  2021-12-20       Impact factor: 10.407

Review 10.  COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.

Authors:  David M Smadja; Steven J Mentzer; Michaela Fontenay; Mike A Laffan; Maximilian Ackermann; Julie Helms; Danny Jonigk; Richard Chocron; Gerald B Pier; Nicolas Gendron; Stephanie Pons; Jean-Luc Diehl; Coert Margadant; Coralie Guerin; Elisabeth J M Huijbers; Aurélien Philippe; Nicolas Chapuis; Patrycja Nowak-Sliwinska; Christian Karagiannidis; Olivier Sanchez; Philipp Kümpers; David Skurnik; Anna M Randi; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2021-06-28       Impact factor: 9.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.